- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Bausch Health Releases Additional Proxy Materials
The pharmaceutical company files new documents ahead of upcoming shareholder vote.
Apr. 8, 2026 at 10:03pm
Got story updates? Submit your updates here. ›
Bausch Health's new proxy materials provide shareholders with additional details to consider ahead of the company's upcoming annual meeting.Washington TodayBausch Health Companies Inc. has filed additional proxy soliciting materials with the U.S. Securities and Exchange Commission as it prepares for an upcoming shareholder vote. The filing includes supplementary information and disclosures related to the company's annual meeting and proposals that will be voted on by investors.
Why it matters
As a publicly traded company, Bausch Health is required to provide detailed information to shareholders ahead of key votes. These proxy materials help investors make informed decisions about the leadership, strategy, and future direction of the business.
The details
The new proxy filing from Bausch Health contains additional disclosures and supplementary information that the company believes is relevant for shareholders to review prior to the annual meeting. This includes details on the board of directors, executive compensation, and specific proposals that will be up for a shareholder vote.
- Bausch Health filed the additional proxy materials on April 8, 2026.
The players
Bausch Health Companies Inc.
A pharmaceutical company that develops and markets a range of branded and generic drugs, medical devices, and over-the-counter products.
The takeaway
The release of these additional proxy materials is a standard part of the process for public companies ahead of shareholder meetings. It provides investors with more context and details to consider before casting their votes on key issues facing the business.
Washington top stories
Washington events
Apr. 8, 2026
The Wiz (Touring)Apr. 8, 2026
Cardi B - Little Miss Drama TourApr. 9, 2026
Wizards v Bulls




